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• 1 % of all malignancies 
• ~5 % of H&N malignancies 
• Europeans: 1: 100,000 
• Asians: 3: 100,000 
Turner, Reh. 2012 
Harvey, Dalgorf. 2013 
• 6730 Non-lymphoreticular malignancies 
• 1973-2006 
Age 6th decade 
Gender Male  (58%) 
Race White (82%) > Black > “Other” 
Epidemiology 
Turner, Reh. 2012 
Epidemiology 







































• Orbital Changes 
• Diplopia 
• Epiphora 
• CN Dysfunction 
• Exophthalmos 
• Headache 
• Facial Swelling 
• Numbness 
Turner, Reh. 2012 




























• Squamous cell ca 
• Lymphoepithelial ca 
• Carcinomas of lacrimal sac 
Salavary 
• Adenocarcinoma 
• Adenoid Cystic Ca 
• Mucoepidermoid Ca 
• Acinic cell ca 
• Carcinoma ex-pleomorphic adenoma 
Mesenchymal 
• Solitary Fibrous Tumors 
• Liposarcoma 
• Fibrosarcoma 
• Malignant Fibrous Histiocytoma 
• Synovial Sarcoma 































• Malignant Peripheral Nerve 
Sheath Tumor 
• Meningioma 
• Neuroendocrine Carcinoma 
• SNUC 
• Ewings 
• Olfactory Neuroblastoma 
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• Extramedullary Plasmacytoma 
Neuroectodermal 
• Malignant Peripheral Nerve 
Sheath Tumor 
• Meningioma 
• Neuroendocrine Carcinoma 
• SNUC 
• Ewings 
• Olfactory Neuroblastoma 
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q amous Cell 
C rcinoma 
Sinonasal Malignancies Squamous Cell 
Carcinoma 
Loevner, Sonners 2002 
Raghavan, Phillips, 2007 
Lung, Howard, Wei. 2014 




<2% 60-70 years of age 
M > F 
Risk Factors…. 
5 year survival: 60% 
• Nickle 
• Chromium 











Surgery, Chemo, XRT 
Sinonasal Malignancies 
Epithelial Epidermoid 
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Aden carcin a 
Sinonasal Malignancies Adenocarcinoma 
Loevner, Sonners 2002 
Raghavan, Phillips, 2007 
Lung, Howard, Wei. 2014 
Ethmoid Sinuses 
Leather & Wood Workers       
Advanced at Presentation:    
   50% cribiform erosion 
Tx: Surgery  XRT 
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Epithelial Epidermoid 
• Squamous cell ca 
• Lymphoepithelial ca 
• Carcinomas of lacrimal sac 
Salavary 
• Respiratory Epithelial 
Adenomatoid Hamartoma 
Mesenchymal 
• Solitary Fibrous Tumors 
• Liposarcoma 
• Fibrosarcoma 
• Malignant Fibrous Histiocytoma 
• Synovial Sarcoma 































• Malignant Peripheral Nerve 
Sheath Tumor 
• Meningioma 
• Neuroendocrine Carcinoma 
• SNUC 
• Ewings 
• Olfactory Neuroblastoma 







Adenoid Cy tic 
C rcinom  
Sinonasal Malignancies Adenoid Cystic 
Carcinoma 
Loevner, Sonners 2002 
Raghavan, Phillips, 2007 
Lung, Howard, Wei. 2014 
~50% ~30% 
~5% 
• Most common salivary neoplasm 
 
• Location: 
• Maxillary > N.C. > 
Sphenoid/Frontal 
 
• Peri-neural spread 
• Extension  orbit & intracranial 
• Difficult to clear  
 
• Treatment: 
• Surgical rsxn 
• Adjuvant XRT 
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• Malignant Peripheral Nerve 
Sheath Tumor 
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Sinonasal Malignancies Rhabdomyosarcoma 
Loevner, Sonners 2002 
Raghavan, Phillips, 2007 
Lung, Howard, Wei. 2014 
Embryonal,  
 Alveolar,  












Treatment: Surgery, Chemo/ 
XRT 
Adults: Ethmoids  
Sinonasal Malignancies 
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• Malignant Peripheral Nerve 
Sheath Tumor 
• Meningioma 
• Neuroendocrine Carcinoma 
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Sinonasal Malignancies Sinonasal Undifferentiated 
Carcinoma 
Loevner, Sonners 2002 
Raghavan, Phillips, 2007 
Lung, Howard, Wei. 2014 
Derived from Schneiderian 
epithelium 
Aggressive neoplasms 
• Advanced presentation 
• 20-30% Cervical LAD 
 
• Metastatic disease 
Rapid growth 
•  Site of origin? 
Mean age of dx: 6th decade 
Treatment Controversial:  
 
• Chemo/XRT w/ surgical salvage 
• Surgery  Chemo/XRT 
Sinonasal Malignancies 
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• Malignant Peripheral Nerve 
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Sinonasal Malignancies Olfactory 
Neuroblastoma 




• 2nd-3rd decade 
• 6-7th decade 
 




• Craniofacial rsxn + XRT 
 
• Long natural history 
• Locoregional recurrence 
• Up to 10 years 
 
• Long term follow up necessary 
Loevner, Sonners 2002 
Raghavan, Phillips, 2007 
Lung, Howard, Wei. 2014 
Sinonasal Malignancies 
Epithelial Epidermoid 
• Squamous cell ca 
• Lymphoepithelial ca 
• Carcinomas of lacrimal sac 
Salavary 
• Respiratory Epithelial 
Adenomatoid Hamartoma 
Mesenchymal 
• Solitary Fibrous Tumors 
• Liposarcoma 
• Fibrosarcoma 
• Malignant Fibrous Histiocytoma 
• Synovial Sarcoma 































• Malignant Peripheral Nerve 
Sheath Tumor 
• Meningioma 
• Neuroendocrine Carcinoma 
• SNUC 
• Ewings 
• Olfactory Neuroblastoma 









Sinonasal Malignancies Mucosal  
Melanoma 
Loevner, Sonners 2002 
Raghavan, Phillips, 2007 
Lung, Howard, Wei. 2014 
~20% Head & Neck 
~2-5% Sinonasal Cavity 
Nasal Septum* 
Turbinate 80% Maxillary Sinus 
Male > Female 
5-7th Decade 
Spread by local invasion 
LN Metastasis 
Treatment: 
• Surgery + XRT 
• Local Failure: 50% 
• Mean Survival: ~2 years  






































Bleier, Lin. 2012 
Suarez, Ferlito, Dpath et. al. 2007 
Orbital invasion by malignancies 
Varies with: 
• Site of origin 
• Histology 
• Tumor Aggressiveness 
Diagnosed at advanced stage 
Orbital Involvement: 
•  60-80%: Maxillary & Ethmoid 
• 30-50% Periorbital Involvement 
Presentation 
Bleier, Lin. 2012 
Loevner, Sonners. 2002 
Essig, Newman, Levine. 2007 
Suarez, Ferlito, Dpath et. al. 2007 
Singh, Eskander, Huang, et.al. 2013 
Ocular Symptoms 62% Ethmoidal Tumors 
46% Nasal Cavity Tumors 
Motility Disturbance (31%) 
Afferent System Dysfunction (29%) 
Proptosis (29%) 
Eyelid Abnormalities (19%) 
Dystopia (17%) 
Lacrimal Outflow Obstruction 
(5%) 
Numb/Pain 
Mechanism of Action 
Bleier, Lin. 2012 
McCary, Levine. 1995 
Singh, Eskander, Huang, et.al. 2013 
All 4 sinuses surround the 
orbit… 
Mechanism of Action 
Bleier, Lin. 2012 
McCary, Levine. 1995 
Singh, Eskander, Huang, et.al. 2013 
All 4 sinuses surround the 
orbit… 
Mechanism of Action 
Bleier, Lin. 2012 
McCary, Levine. 1995 
Singh, Eskander, Huang, et.al. 2013 
All 4 sinuses surround the 
orbit… 
Mechanism of Action 
Bleier, Lin. 2012 
McCary, Levine. 1995 
Singh, Eskander, Huang, et.al. 2013 
Opportunities for orbital 
extension 
• Multiple foramina 
• Perforating nerves/ vessels 
• Thin bones 
• Lacrimal fossa 
• Lamina papyracea 
• Periorbita 
No natural  
intra/extra-conal barriers 
“Orbital Invasion” 
Curtin, Rabinov. 1998 
Kim, Lee, Lee, et.al. 2015 
Carrau, Segas, Nuss, et.al. 1999 
Suarez, Ferlito, Dpath et. al. 2007 
Iannetti, Valentini, Rinna, et.al. 2005 








Suarez, Ferlito, Dpath et. al. 2007 
Iannetti, Valentini, Rinna, et.al. 2005 
Singh, Eskander, Huang, et.al. 2013 
Curtin, Rabinov. 1998 
Kim, Lee, Lee, et.al. 2015 
Carrau, Segas, Nuss, et.al. 1999 
Periorbita 
• “True protector” of orbit 
 
• Intact despite bone 
erosion 
 
• Defines orbital invasion? 
 
• Degree of invasion 
 
• Partial vs. Full 
thickness? 
“Orbital Invasion” 
Curtin, Rabinov. 1998 
Kim, Lee, Lee, et.al. 2015 
Carrau, Segas, Nuss, et.al. 1999 
Suarez, Ferlito, Dpath et. al. 2007 
Iannetti, Valentini, Rinna, et.al. 2005 
Singh, Eskander, Huang, et.al. 2013 
Orbital Invasion- 35-75% of cases 
McCary et al 
Discordant defintions 
• A: Adj to orbit, no wall  
 
• B: Wall erosion, no globe 
   displacement 
 
• C: Wall erosion & 
    infiltration, no periorbita 
 
• D: Invades orbit & periorbita 
Ianetti et al 
• I:  Wall erosion 
 
• II: Orbital fat 
 
• III: MR, globe, ON, 
    palpebral skin 
No Agreement 
Prognosis 
Bleier, Lin. 2012 
Ganly, Patel, Singh et al. 2005 
Suarez, Ferlito, Dpath et. al. 2007 
Poor Prognosis 
Ganly et al 2005 
334 pts CFR for ethmoid 
tumors 
LACK of orbital invasion… 
• Predict recurrence 
free, disease 
specific and overall 
survival 
 
• DSS:  
• + Orbit: 41% 
• -  Orbit: 75% 
Orbital soft tissue 
involvement 
 
• Independent factor 
influencing survival  
Invasion limited to 
periorbita 
 






























Loevner, Sonners. 2002 
Kim, Lee, Lee, et.al. 2006 
• No symptoms  
 




Directly abut the 
orbit w/o bone 
invasion 






Loevner, Sonners. 2002 
Kim, Lee, Lee, et.al. 2006 
Eisen, Yousem, Loevner, et.all. 2000 



























• Tumor in 
duct or sac 
• No one criterion had accuracy >79% 
• > 6 criteria predicted orbital invasion w/ accuracy 72%. 
• Adjacent to periorbita: most sensitive (90%), low specificity (29-44%) 
• EOM enlargement:  most specific (94%) 
• Orbital Fat Involvement: specific, high PPV, but less sensitive  
 
• Low Sensitivity (40% MRI, 60% CT) 
Conclusions 
Imaging 
Loevner, Sonners. 2002 
Kim, Lee, Lee, et.al. 2006 
• Evaluate bone, fat interface 
• Compresses vs. invades 
periorbita 




Loevner, Sonners. 2002 
Kim, Lee, Lee, et.al. 2006 
Erosion of 
lateral nasal wall 







Loevner, Sonners. 2002 
Kim, Lee, Lee, et.al. 2006 
Eisen, Yousem, Loevner, et.al. 2000 




Invasion of the periorbita: 
 
• Results in loss of signal 
Imaging 
Loevner, Sonners. 2002 
Kim, Lee, Lee, et.al. 2006 
Eisen, Yousem, Loevner, et.al. 2000 





signal in fat 
Tumor Nodularity 
Mass Effect of 
Medial Rectus 
Loss of fat signal 
Imaging 
Loevner, Sonners. 2002 









































Bleier, Lin. 2012 
Suarez, Ferlito, Lund, et.al. 2008 







1. Oncological Safety of Orbital Preservation 
 
2. Functional Outcome in Preserved Eyes. 
Orbital Exenteration 
Support for 
Bleier, Lin. 2012 
Imola, Schramm. 2002 
Dulgerov, Jacobsen, Allal et.al. 2001 
Imola 2002 
1. Involvement of the orbital apex 
 
2. Non-resectable full-thickness invasion through periorbita into retrobulbar 
fat 
 
3. Extension into the EOM 
 
4. Invasion of the bulbar conjunctiva 
 
5. Lid involvement beyond reasonable hope for reconstruction 
• Study over 200 pts 
• Local control rate:  
• 79% with exenteration 
• 14% without exenteration 
Probably unwise to conclude 




Rajapurkar, Thankappan, Mohan et.al. 2013 
Anderson (1996) 
• 32% incidence of non-functional eye 
• 58 patients- anterior CFR, orbit preservation, adjuvant 
XRT 
“Strong consideration for orbital exent based 
on anticipated poor functional outcomes” 
 
Rajapurkar (2013) 
• 19 total/radical maxillectomy 
• 4/19- orbital floor + periorbita + Fat (orbit preserved) 
• ¾- orbital + margins (despite XRT) 
• Recurred 
If cant ensure complete negative orbital 




   Against 
Conley 1985 
Bleier, Lin. 2012 
McCary, Levine. 1995 
Contraindications 
• Brain? 
• Cavernous Sinus 
• Carotid Artery 
• Bilateral Optic n. 
• Optic Chiasm 
Psychosocial • 27 patients  Orbital Preservation 
• All were glad eye was spared 
The cosmetic, functional, and psychologic consequences of loss of an 
eye mandate that every effort should be made to preserve the eye as 
long as oncologic safety is not compromised.” 
Orbital Exenteration 
Support 
   Against 
Conley 1985 
Bleier, Lin. 2012 
McCary, Levine. 1995 
Reyes, Mason, Solares, et.al. 2015 
No strong evidence favoring preservation vs. exenteration 
Criticisms: 
• Tumor histology not taken into account.   
• Effect may be limited to SCC, Adenoca 
• Different indications for exenteration 
• Preserved: not description of what resected 
Reyes, mason, Solares, Bush, Carrau. 2015 
Orbital Exenteration 
Straub. 1988 
McCary, Levine. 1995 
Imola, Schramm. 2002 
Perry, Levine, Williamson,et.al. 1988 
1583 
Bartisch 
• “Starved” the day of the operation 
• Held down by 2 assistants 
• No anesthesia 
• Pass needle & silk thread through globe 
• Exerting forward traction 
• Cut attachments to eye with curved knife 
• Bandage placed 
• Enriched with sulfered spelter and brandy 
Orbital Exenteration 
Nemet, Martin, Benger, et.al. 2007 
Involves removal of the soft tissue contents of the orbit, including the 
globe.   
:  
• globe, eyelid, conjunctiva, orbital contents, periorbita 
:  
• bony orbital walls, paranasal sinuses, + intracranial tissue 
:  

















Orbital Preservation/ XRT 
Imola, Schramm. 2002 
No statistically significant difference in 
recurrence rates 
Eye preservation could be attempted in any malignancy that invaded the 
orbital soft tissues with penetration through the periorbita provided that it 
could be easily and completely dissected away from the orbital fat.  
Orbital Preservation/ XRT 




Disease-free survival in patients with orbital invasion 




Preservation of the orbit, when the full thickness of periorbita is not 
invaded, does not downgrade outcome and therefore supports a 
trend toward orbital preservation. 
Survival:    Sinonasal Malignancy 
Turner, Reh. 2012 































Surgery + XRT 
No Treatment 
Not specific to orbital invasion 
Orbital Preservation/ XRT 
McCary, Levine. 1995 
McCary, Levine, Cantrell. 1996 
Xuexi, Pingzhang, Yongfa. 1995 
University of Virginia Protocol (SNUC, Esthesio) 
• Preop XRT 
• Effort to spare globe, lacrimal gland 
 
• Chemo? 
• Salvage surgery 
• 33 patients: Orbital invasion 
• Invaded bone & displaced periorbita 
• Grossly invaded the orbit & periorbita 
• No eyes removed 
• 5/33: Local recurrence 
• 1/5: in orbit 
• Reduce tumor size 
 
• Tumor in orbit 















































• Disease-specific management 
 
• Research 
Sequela of Function 
Points of Contention 




Functional Outcome in Preserved Eyes 






Sequela of Function 
Surgery alone 
Bleier, Lin. 2012 
Suarez, Ferlito, Lund, et.al. 2008 
Imola, Schramm 2002 
Functional without impairment 


















Sequela of Function 
radiation alone 
Loss of Ocular 
Function 
• Ipsilateral Orbit: 79% 
 
• Contralateral Orbit: 5% 
Stern, Goepfert, Clayman, et.al. 1993 
Sequela of Function 
radiation alone 
Loss of Ocular 
Function 
Imola, Schramm. 2002 
Sequela of Function 
Surgery & radiation  
McCary 1996 
• 29/ 33-  
• Pre-op XRT 
• Rsxn of periorbita 
• 55%: No ophthalmic problems 
• 45%: 
• Exposure Keratitis (6 pts) 
• Motility Disturbance (6 pts) 






 MCCary, Levine, Cantrell. 1996 
Bleier 2012, 
Suarez 2008 
• Increased risk of: 
 
• Otpic atrophy 
• Cataracts 






























Suarez, Ferlito, Lund, et.al. 2008 
Sparing the soft tissues of the orbit when the 
periorbita have not been deeply transgressed 
by tumor generally does not appear to 
adversely affect local control.   
Outcomes… 




• More advanced tumors  Exenteration 
• More favorable tumors    Preservation 
• Plays significant role in outcome 
Local Recurrence 
Histologic Subtype 
Imola, Schramm. 2002 
Not Statistically 
Significant 
Low numbers of each histology 
Conclusions… 
Imola, Schramm. 2002 
Periorbita not deeply transgressed 
 Does not affect local control/survival 
 
 Preserve orbit 
 
Tumor histology/behavior matters 
Surgery/XRT- Preserved eye with variable level of 
function 





























… 1. Evaluate recurrence and survival rates based 




2. Stratify based on extent of tumor resection & 
degree of invasion 
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